Canada Life’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Canada Life’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-17,600	Closed	-$298K	–	2633
2014 Q4	$298K	Hold	17,600	–	–	﹤0.01%	1115
2014 Q3	$210K	Buy	+17,600	New	+$120K	﹤0.01%	1201

Canada Life's AVNR Position: Q1 2015 in Review

Canada Life sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 17,600 shares — an estimated $298K sold.

Canada Life first reported a position in AVNR in Q3 2014 and held it in 2 quarters. The position peaked at $298K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Canada Life reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Canada Life sold 17,600 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $298K.
Canada Life first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 2 quarters.
Canada Life's AVANIR PHARMACEUTICALS, INC CL A position peaked at $298K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Canada Life's 13F filing for Q1 2015, filed 6 May 2015.